Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
318 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (5)
  • Currently Recruiting (3)
  • (-) Closed (2)

Medical Condition

  • Show all (1625)
  • Addiction (14)
  • Allergy, Asthma, & Immunology (12)
  • All of Us Research Program - NIH (1)
  • Autoimmune Disorders (26)
  • Blood Disorders (37)
  • Bone & Muscle (8)
  • Cancer (661)
  • Child Development (4)
  • COVID-19 (Coronavirus) (28)
  • Critical Illness (1)
  • Diabetes (15)
  • Ear, Nose and Throat (5)
  • Endocrine & Metabolic Disease (11)
  • Eye (7)
  • Gastrointestinal and Digestive Diseases (21)
  • Hair and Skin Disorders (1)
  • Headaches (5)
  • Healthy Volunteers (139)
  • Heart Disease (108)
  • Infectious Disease (37)
  • Insomnia (2)
  • Kidney Disease (12)
  • Liver Disease (40)
    • Cirrhosis of the Liver (4)
    • Hepatic Encephalopathy (2)
    • Hepatitis (11)
    • (-) Liver Failure (1)
    • NASH (3)
  • Lung Disease (29)
  • Meniere's Disease (1)
  • Neurological Disorders (138)
    • Alzheimer's Disease (31)
    • Brain Tumors (50)
    • Dementia (5)
    • Huntington's Disease (2)
    • Multiple Sclerosis (5)
    • Neuromuscular (9)
    • Neuropathy (11)
    • (-) Parkinson's Disease (1)
  • Nutrition (6)
  • Obesity (2)
  • Obstetrics & Gynecology (43)
  • Pain Management (1)
  • Pediatrics (82)
  • Psychiatric Disorders (59)
  • Rehabilitation (7)
  • Stroke (5)
  • Surgery (7)
  • Transplant (37)
  • Urology (4)
  • Vascular Conditions (9)
Displaying 1 - 2 of 2

Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)

Condition: Liver Disease / Liver Failure
Investigator: Elizabeth Verna, MD
Status: Closed
The purpose of this research study is to determine if an investigational drug, VS-01, will help in the treatment of acute-on-chronic liver failure (ACLF) compared to supportive care (standard of therapy). ACLF is a potentially life-threatening condition characterized by a group of signs that occur together (syndrome) in patients with a late stage of…
Read More

Parkinson's Disease Genetic Study: FoxBioNet ECV-004

Condition: Neurological Disorders / Parkinson's Disease
Investigator: Julian Agin-Liebes, MD
Status: Closed
FoxBioNet ECV-004 is an observational study sponsored by the Michael J. Fox Foundation for Parkinson's Research. The purpose of this study is to investigate a gene called LRRK2. Mutations in the LRRK2 gene are associated with Parkinson's disease (PD), and mutation carriers have greater LRRK2 protein activity. The goal of this study is to identify…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science